Work

Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Journal of Infectious Diseases

DOI: 10.1093/infdis/jit365

Authors: R. Chlibek, J. M. Bayas, H. Collins, M. L. R. de la Pinta, E. Ledent, J. F. Mols, T. C. Heineman

Institutions: University of Defence, Hospital Clínic de Barcelona, Hospital Universitario Puerta de Hierro Majadahonda, GlaxoSmithKline (Belgium), GlaxoSmithKline (United States)

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2145061830

FWCI: 6.776

Cites: 22

Cited by: 149

Related to: 10